An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Completed · Phase 2 · NCT05848258
Conditions: Rheumatoid Arthritis
At a glance
- Research payments reported, 2025
- $1.0M
- U.S. investigators named
- 14
- Sites paid
- 16
- Planned or actual enrollment
- 164
About the trial
- Sponsor
- Eli Lilly and Company (with Rigel Pharmaceuticals)
- Tested
- LY3871801 (drug), Placebo (drug)
- Dates
- Started 2023-05-23; completion 2026-04-22
- Results posted
- Not yet
The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid arthritis (RA).
From ClinicalTrials.gov, last updated 2026-05-22. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $1.0M in research payments for this study in 2025 (33 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Christine T. Thai, M.D. Rheumatology · Huntington Beach, CA
- Jude A. Acloque, M.D. Internal Medicine · Boynton Beach, FL
- Shaheed M. Ali, MD Internal Medicine · Ocoee, FL
- Mariangeli Arroyo-avila, M.D. Rheumatology · Ocoee, FL
- Adolfo A. Cueli, M.D. Family Medicine · Homestead, FL
- Anand A. Patel, MD Pain Medicine · Ormond Beach, FL
- Christopher G. Gibson, DO Rheumatology · Ashton, ID
- Angela R. Crowley, M.D. Rheumatology · Willowbrook, IL
- Enrique A. Mendez, M.D. Rheumatology · Lake Charles, LA
- Rakesh C. Patel, DO Rheumatology · Salisbury, NC
- Yousaf Ali, MD Rheumatology · New York, NY
- David H. Goddard, MD Rheumatology · Brooklyn, NY
- Philip A. Waller, M.D. Rheumatology · Houston, TX
- Deepa Gali, MD Rheumatology · Lakewood, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Accurate Clinical Research Inc $238,983
- Encore Medical Research of Weston LLC $221,428
- Conquest Research LLC $213,407
- Newport Huntington Medical Group $72,321
- Advanced Clinical Research of Orlando Ocoee $67,242
- New York University $56,916
- Integrity Clinical Research LLC $56,136
- Overlake Arthritis and Osteoporosis Center $22,692
- Crowley Core LLC $14,371
- Bingham Memorial Hospital $13,220
- Piedmont Medical Research Associates Inc $12,675
- Capital Clinical Research Center PLLC $5,426
- $2,400
- Johnson Dermatology PLLC $1,273
- Encore Medical Research, LLC $720
- Brain Matters Research Inc $660
- Hoag Memorial Hospital Presbyterian $210
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.